ArticlePloS one2019

Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study.

Yosuke Takakusagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.